Strikingly, all Cux1+/−;Flt3ITD mice developed lethal hematologic disease with a median survival of 28 weeks, while control (Con) and single-allele (Cux1+/− and Flt3ITD) groups remained healthy (Fig. 2a). Here, CUX1 is linked to hematologic disorder.